Guy Bernstein

Dr. Guy Bernstein MD

Attending Urologic Surgeon, MAIN LINE HOSPITALS, INC.


          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Member of the Healthcare Council

Request a consultation with Guy Bernstein

Council Member Biography

Guy Bernstein, MD, is President and Practicing Urologist at the Center for Urologic Care in Bryn Mawr, Pennsylvania. In addition, Dr. Bernstein has served as Attending Urologic Surgeon at Bryn Mawr Hospital since 1988. He is experienced in all aspects of urology with special interest in erectile dysfunction, male infertility, incontinence, benign prostatic hypertrophy, prostatitis and prostate cancer. He is certified in laparoscopic and laser surgery, cryosurgery and brachytherapy for prostate cancer, minimal invasive heat treatments for BPH and sling procedures for male and female incontinence. Dr. Bernstein is Vice-Chairman of the Main Line Hospitals Institutional Review Board, and has participated in clinical trials for GlaxoSmithKline, Ortho-McNeil, Novartis, Genomics, Sanofi-Synthelabo, Solvay, Myriad, Dendreon and Pfizer. He is a member of the speaker's bureau for Ortho-McNeil, GlaxoSmithKline, Sanofi-Synthelabo, Lilly Icos and Auxilium. Dr. Bernstein has investigator experience with Provenge. (This is me - Update Profile)


Employment History

1998 - Unspecified
Attending Urologic Surgeon, MAIN LINE HOSPITALS, INC.
1995 - 2006
Clinical Assistant Professor of Urology, Jefferson Medical College
1988 - Unspecified
President, The Center for Urologic Care

GLG NewsSM Analyses by Guy Bernstein

Opinions and analyses expressed in G+ Insights are solely those of the author. See the Terms of Use for details.


GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

ED and cardiovascular disease are linked

August 11, 2006

Impotence could be sign of heart disease, study says | www.cnn.com

Erectile dysfunction may be the first indicator of serious cardiovasulcar disease which warrants evaluation and treatment.

Crowded Field of OAB Medications

August 11, 2006

Trospium Chloride Meets Primary and Secondary Endpoints in Phase 3 Trial | www.ptcommunity.com

Phase III trial of Sanctura XR shows efficacy in treatment of OAB with reduced side effect of dry mouth.